Search Results - "Molokov, V. A."

The effect of bisphosphonate therapy on reducing the risk of cardiovascular complications associated with chronic heart failure, type 2 diabetes and osteoporosis in postmenopausal women by Teplyakov, A T, Berezikova, E N, Shilov, S N, Popova, A A, Samsonova, E N, Yakovleva, I V, Molokov, A V, Grakova, E V, Kopeva, K V

“…Aim. To study the effectiveness of oral alendronate and ibandronate bisphosphonates for the prevention of cardiovascular complications in postmenopausal women…”
Get full text

Helium in groundwaters of the Altai Republic by Dutova, E. M., Kats, V. E., Shitov, A. V., Surnin, A. I., Molokov, V. A.

“…This study of groundwaters of the Altai Republic is relevant due to the need to identify earthquake precursors in seismically active zones of the study area…”
Get full text

Cardioprotective effects of alendronate bisphosphonate in patients with ischemic heart disease associated with type 2 diabetes mellitus and osteoporosis by Shilov, S. N., Berezikova, E. N., Popova, A. A., Samsonova, E. N., Teplyakov, A. T., Grakova, E. V., Kopeva, K. V., Molokov, A. V., Yakovleva, I. V.

“…Introduction . Diabetes mellitus, cardiovascular diseases and osteoporosis are linked by common pathophysiological mechanisms. Objective . To evaluate the…”
Get full text

Osteoprotegerin is a new independent predictor of the progression of cardiovascular pathology: chronic heart failure associated with type 2 diabetes and osteoporosis by Teplyakov, A. T., Berezikova, E. N., Shilov, S. N., Popova, A. A., Yakovleva, I. V., Molokov, A. V., Grakova, E. V., Kopeva, K. V., Svarovskaya, A. V., Garmaeva, O. V., Torim, Yu. Yu, Stepachev, E. I., Kalyuzhin, V. V.

“…Aim. To study the link of increased serum concentrations of osteoprotegerin (OPG) in patients with chronic heart failure (CHF) associated with type 2 diabetes…”
Get full text

Nilpotent groups of finite algorithmic dimension by Goncharov, S. S., Molokov, A. V., Romanovskii, N. S.

Get full text